Gut Microbiota Modulates Obesity‐Associated Skeletal Deterioration Through Macrophage Aging and Grancalcin Secretion

• Published in: Advanced science Vol. 12; no. 28; pp. e2502634 - n/a
• Main Authors: Huang, Min, Huang, Mei, Liu, Ling, Yang, Fang, He, Chen, Sun, Yu‐Chen, Jiao, Yu‐Rui, Tang, Xiang, Hou, Jing, Chen, Kai‐Xuan, He, Wen‐Zhen, Wei, Jie, Chen, Hui‐Ling, Li, Xia, Zeng, Chao, Lei, Guang‐Hua, Li, Chang‐Jun
• Format: Journal Article
• Language: English
• Published: Germany John Wiley & Sons, Inc 01.07.2025; John Wiley and Sons Inc; Wiley
• Subjects: Aging; Animals; Antibiotics; Bacteria; Bone marrow; Cellular Senescence; Chronic illnesses; Feces; Female; Fractures; Gastrointestinal Microbiome - physiology; Genes; Gram-negative bacteria; grancalcin; Gut microbiota; Homeostasis; Humans; Immune system; immunosenescence; Inflammation; Macrophages - metabolism; Male; Metabolic disorders; Mice; Mice, Inbred C57BL; Obesity; Obesity - complications; Obesity - metabolism; Obesity - microbiology; Senescence; Signal transduction; skeletal deterioration; gut‐microbiota; immunosenescence; grancalcin; skeletal deterioration; obesity
• ISSN: 2198-3844; 2198-3844
• DOI: 10.1002/advs.202502634

Obesity is associated with skeletal deterioration and increased fracture risk, but the underlying mechanism is unclear. Herein, it is shown that obese gut microbiota promotes skeletal deterioration by inducing bone marrow macrophages (BMMs) senescence and grancalcin (GCA) secretion. Obese mice and those receiving obese fecal microbiota transplants exhibit increased senescent macrophages and elevated GCA expression in the bone marrow. In a study of 40 participants, it is found that obese patients are associated with higher serum GCA levels. It is further revealed that obese gut‐microbiota derived lipopolysaccharides (LPS) stimulate GCA expression in senescent BMMs via activating Toll‐like receptor 4 pathway. Mice with depletion of the Gca gene are resistant to the negative effects of obesity and LPS on bone. Moreover, neutralizing antibody against GCA mitigates skeletal deterioration in obese mice and LPS‐induced chronic inflammation mouse model. The data suggest that the interaction between gut microbiota and the immune system contributes to obesity‐associated skeletal deterioration, and targeting senescent macrophages and GCA shows potential of protecting skeletal health in obese population. Obese gut‐microbiota derived lipopolysaccharides (LPS) induce bone marrow macrophage senescence and GCA secretion via activating TLR4/NF‐κB/MAPKs pathway. Clinically, obese patients are associated with higher serum GCA levels. Mice with depletion of GCA gene show resistance to skeletal deterioration caused by obesity and LPS‐induced chronic inflammation. GCA‐neutralizing antibody shows potential of ameliorating skeletal deterioration in obese and chronic inflammation mouse model.